63 results
8-K
EX-10.2
ABVC
ABVC BioPharma Inc
9 May 24
Entry into a Material Definitive Agreement
9:27am
) allowance, discount or rebate for rejection, defect, recall, return, retroactive price reduction
Net Sales shall be accounted in accordance with arm
8-K
EX-10.1
ABVC
ABVC BioPharma Inc
9 May 24
Entry into a Material Definitive Agreement
9:27am
or rebate for rejection, defect, recall, return, retroactive price reduction
Net Sales shall be accounted in accordance with arm-length principles
POS AM
ABVC
ABVC BioPharma Inc
25 Apr 24
Prospectus update (post-effective amendment)
2:38pm
applicable regulatory requirements can result in criminal prosecution, fines, imprisonment or other penalties, injunctions, recall or seizure … to product labeling; (iii) the recall or discontinuation of our products; or (iv) additional record-keeping requirements. If any such changes were
8-K
EX-10.1
ABVC
ABVC BioPharma Inc
17 Apr 24
Entry into a Material Definitive Agreement
8:30am
for rejection, defect, recall, return, retroactive price reduction
Net Sales shall be accounted in accordance with arm-length principles, industry
8-K
EX-10.2
ABVC
ABVC BioPharma Inc
17 Apr 24
Entry into a Material Definitive Agreement
8:30am
, discount or rebate for rejection, defect, recall, return, retroactive price reduction
Net Sales shall be accounted in accordance with arm-length
424B4
rk73ofq3b9p t2lxk
5 Apr 24
Prospectus supplement with pricing info
2:47pm
8-K
EX-10.2
khdbmba23 pe37
26 Mar 24
Entry into a Material Definitive Agreement
8:35am
8-K
EX-10.1
tg17sf723g wel0p7n
26 Mar 24
Entry into a Material Definitive Agreement
8:35am
DEFA14A
vk7w7s63nwo8dyds7gex
25 Mar 24
Additional proxy soliciting materials
4:30pm
8-K
EX-10.1
bbzeb2
2 Aug 23
ABVC Signs a Term Sheet to Earn Licensing Fees of up to $20M and Royalties of 5-12% of Net Sales
5:00pm
424B4
76sv6
12 Jun 23
Prospectus supplement with pricing info
4:30pm